Cell mediated immunity assays identify proteins of diagnostic and vaccine potential from genomic regions of difference of Mycobacterium tuberculosis

Kuwait Medical Journal

Volumn 42, Issue 2, 2010, Pages 98-105

  Mustafa, Abu Salim ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

CMI; Diagnosis; RD antigens; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN; RECOMBINANT PROTEIN; TUBERCULIN;

BACTERIAL GENOME; CELLULAR IMMUNITY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; GENOMICS; HUMAN; IMMUNOASSAY; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; OPEN READING FRAME; PROTEIN PURIFICATION; REVIEW; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 77954877471     PISSN: 00235776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Global tuberculosis control: epidemiology, strategy, financing. WHO Report 2009 WHO/HTM/TB/2009.411. (Accessed July 8, 2009, at http://www.who.int/tb/publications/global_report/2009/en/index.html).
2. Smith R. Eradication of tuberculosis by 2050 impossible without new vaccine. BMJ 2009; 338:b1291.
3. Crampin AC, Glynn JR, Fine PE. What has Karonga taught us? Tuberculosis studied over three decades. Int J Tuberc Lung Dis 2009; 13:153-164.
4. Moffitt MP, Wisinger DB. Tuberculosis. Recommendations for screening, prevention, and treatment. Postgrad Med 1996; 100:201-204.
5. Leung CC, Yew WW, Tam CM, et al. Tuberculin response in BCG vaccinated school children and the estimation of annual risk of infection in Hong Kong. Thorax 2005; 60:124-129.
6. Mahadevan B, Mahadevan S, Serane VT, Narasimhan R. Tuberculin reactivity in tuberculous meningitis. Indian J Pediatr 2005; 72:213-215.
7. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005; 3:656-662.
8. Castanon-Arreola M, Lopez-Vidal Y. A second-generation anti TB vaccine is long overdue. Ann Clin Microbiol Antimicrob 2004; 3:10.
9. Hesseling AC, Caldwell J, Cotton MF, et al. BCG vaccination in South African HIV-exposed infants - risks and benefits. S Afr Med J 2009;99:88-91.
10. Dockrell HM. Real vaccines in the real world: tuberculosis vaccines move south. Expert Rev Vaccines 2008; 7:703-707.
11. Lönnroth, K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 2008; 29:481-491.
12. Ly LH, McMurray DN. Tuberculosis: vaccines in the pipeline. Expert Rev Vaccines 2008; 7:635-650.
13. Skeiky YA, Sadoff JC. Advances in tuberculosis vaccine strategies. Nat Rev Microbiol 2006; 4:469-476.
14. Mustafa AS. Progress towards the development of new anti-tuberculosis vaccines, In: Smith LT, editor. Focus on Tuberculosis Research. New York: Nova Science Publishers Inc; 2005. p 47-76.
15. Aagaard C, Dietrich J, Doherty M, Andersen P. TB vaccines: current status and future perspectives. Immunol Cell Biol 2009; 87:279-286.
16. Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999; 284:1520-1523.
17. de Jonge MI, Brosch R, Brodin P, Demangel C, Cole ST. Tuberculosis: from genome to vaccine. Expert Rev Vaccines 2005; 44:541-451.
18. Mustafa AS. Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 2002; 39:113-119.
19. Mustafa AS. Mycobacterial gene cloning and expression, comparative genomics, bioinformatics and proteomics in relation to the development of new vaccines and diagnostic reagents. Med Princ Pract 2005; 14:S27-S34.
20. Mustafa AS. Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. Curr Pharm Biotechnol 2001; 2:157-173.
21. Malen H, Berven FS, Fladmark KE, Wiker HG. Comparative analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 2007; 7:1702-1718.
22. Amoudy HA, Mustafa AS. Amplification of six putative RD1 genes of Mycobacterium tuberculosis for cloning and expression in Escherichia coli and purification of expressed proteins. Med Princ Pract 2008; 17:378-384.
23. Ahmad S, Akbar PK, Wiker HG, Harboe M, Mustafa AS. Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon of Mycobacterium tuberculosis. Scand J Immunol 1999; 50:510-518.
24. Ahmad S, Ali MM, Mustafa AS. Construction of a modified vector for efficient purification of recombinant Mycobacterium tuberculosis proteins expressed in Escherichia coli. Protein Expr Purif 2003; 29:167-175.
25. Ahmad S, El-Shazly S, Mustafa AS, Al-Attiyah R. Mammalian cell-entry proteins encoded by the mce3 operon of Mycobacterium tuberculosis are expressed during natural infection in humans. Scand J Immunol 2004; 60:382-391.
26. Ahmad S, El-Shazly S, Mustafa AS, Al-Attiyah R. The six mammalian cell entry proteins (Mce3A-F) encoded by the mce3 operon are expressed during in vitro growth of Mycobacterium tuberculosis. Scand J Immunol 2005; 62:16-24.
27. Mustafa AS, Skeiky YA, Al-Attiyah R, Alderson MR, Hewinson RG, Vordermeier HM. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle. Infect Immun 2006; 74:4566-4572.
28. Amoudy HA, Ahmad S, Thole JE, Mustafa AS. Demonstration of in vivo expression of a hypothetical open reading frame (ORF-14) encoded by the RD1 region of Mycobacterium tuberculosis. Scand J Immunol 2007; 66:422-425.
29. Daugelat S, Kowall J, Mattow J, et al. The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes Infect 2003; 5:1082-1095.
30. Mustafa AS. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance. Tuberculosis (Edinb) 2005; 85:367-376.
31. Oftung F, Geluk A, Lundin KE, et al. Mapping of multiple HLA class II-restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein. Infect Immun 1994; 62:5411-5418.
32. Ravn P, Demissie A, Eguale T, et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 1999; 179:637-645.
33. Mustafa AS, Lundin KE, Meloen RH, Shinnick TM, Oftung F. Identification of promiscuous epitopes from the Mycobacterial 65-kilodalton heat shock protein recognized by human CD4 (+) T cells of the Mycobacterium leprae memory repertoire. Infect Immun 1999; 67:5683-5689.
34. Mustafa AS, Lundin KE, Meloen RH, Oftung F. Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein. Clin Exp Immunol 2000; 120:85-92.
35. Mustafa AS, Cockle PJ, Shaban F, Hewinson RG, Vordermeier HM. Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin Exp Immunol 2002; 130:37-42.
36. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 2003; 38:249-256.
37. Mustafa AS, Oftung F, Amoudy HA, et al. Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specifichumanTcell lines. Clin Infect Dis 2000; 30:S201-S205.
38. Al-Attiyah R, Shaban FA, Wiker HG, Oftung F, Mustafa AS. Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect Immun 2003; 71:1953-1960.
39. Mustafa AS, Shaban FA, Al-Attiyah R, et al. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol 2003; 57:125-134.
40. Al-Attiyah R, Mustafa AS. Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect Immun 2008; 76:4190-4198.
41. Mustafa AS, Al-Attiyah R. Identification of Mycobacterium tuberculosis-specific genomic regions encoding antigens inducing protective cellular immune responses. Indian J Exp Biol 2009; 47:498-504.
42. Al-Attiyah RJ, Mustafa AS. Mycobacterial antigen-induced T helper type 1(Th1) and Th2 reactivity of peripheral blood mononuclear cells of diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG) vaccinated healthy subjects. Clin Exp Immunol 2009; 158:64-73.
43. Mustafa AS. HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design. Hum Immunol 2000; 61:166-171.
44. Mustafa AS, Al-Attiyah R. Tuberculosis: looking beyond BCG vaccines. J Postgrad Med 2003; 49:134-140.
45. Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 2004; 4:93-101.
46. Al-Attiyah R, Madi N, El-Shamy AS, Wiker H, Andersen P, Mustafa A. Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 2006; 47:254-261.
47. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364:2196-2203.
48. Bai X, Wilson SE, Chmura K, Feldman NE, Chan ED. Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis (Edinb) 2004; 84:375-385.
49. Jo EK, Park JK, Dockrell HM. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 2003; 16:205-210.
50. Turner J, Gonzalez-Juarrero M, Ellis DL, et al. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 2002; 169:6343-6351.
51. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997; 158:315-321.
52. Murray PJ, Young RA. Increased antimycobacterial immunity in interleukin-10 deficientmice. Infect Immun 1999; 67:3087-3095.
53. Jamil B, Shahid F, Hasan Z, et al. Interferon gamma/IL-10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 2007; 87:279-287.
54. Sahiratmadja E, Alisjahbana B, de Boer T, et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007; 75:820-829.
55. Mustafa AS, Lundin KE, Meloen RH, Shinnick TM, Oftung F. Identification of promiscuous epitopes from the Mycobacterial 65-kilodalton heat shock protein recognized by human CD4 (+) T cells of the Mycobacterium leprae memory repertoire. Infect Immun 1999; 67:5683-5689.
56. Mustafa AS, Shaban FA, Abal AT, et al. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific humanCD4(+) T-cell lines. Infect Immun 2000; 68:3933-3940.
57. Mustafa AS, Lundin KE, Meloen RH, Shinnick TM, Oftung F. Identification of promiscuous epitopes from the Mycobacterial 65-kilodalton heat shock protein recognized by human CD4 (+) T cells of the Mycobacterium leprae memory repertoire. Infect Immun 1999; 67:5683-5689.
58. Mustafa AS, Lundin KE, Oftung F. Isolation of recombinant phage clones expressing mycobacterial T cell antigens by screening a recombinant DNA library with human CD4+ Th1 clones. FEMS Immunol Med Microbiol 1998; 22:205-216.
59. Al-Attiyah R, Mustafa AS. Computer-assisted prediction of HLA-DR binding and experimental analysis for human promiscuous Th1-cell peptides in the 24 kDa secreted lipoprotein (LppX) of Mycobacterium tuberculosis. Scand J Immunol 2004; 59:16-24.
60. Al-Attiyah R, Mustafa AS, Abal AT, El-Shamy AS, Dalemans W, Skeiky YA. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Clin Exp Immunol 2004; 138:139-144.
61. Mustafa AS, Abal AT, Shaban F, El-Shamy AM, Amoudy HA. HLA-DR binding prediction and experimental evaluation of T-cell epitopes of mycolyl transferase 85B (Ag85B), a major secreted antigen of Mycobacterium tuberculosis. Med Princ Pract 2005; 14:140-146.
62. Mustafa AS.Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis. Scand J Immunol 2009; 69:213-222.
63. Mustafa AS. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med Princ Pract 2009; 18:385-392.
64. Mustafa AS, Amoudy HA, Wiker HG, Abal AT, Ravn P, Oftung F, Andersen P. Comparison of antigen-specificT-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol 1998; 48:535-543.
65. Weldingh K, Andersen P. Immunological evaluation of novel Mycobacterium tuberculosis culture filtrateproteins. FEMS Immunol Med Microbiol 1999; 23:159-164.
66. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286:1740-1747.
67. Katti MK. Assessment of RD 1-encoded mycobacterial antigens in the immunodiagnosis of pulmonary, extrapulmonary, and latent tuberculosis infections. J Infect Dis 2001; 184:1497-1498.
68. Mustafa AS, Al-Attiyah R. Mycobacterium tuberculosis antigens and peptides as new vaccine candidates and immunodiagnostic reagents against tuberculosis. KMJ 2004; 36:171-176.
69. Hanif SNM, El-Shammy AM, Al-Attiyah R, Mustafa AS. Whole blood assays to identify Th1 cell antigens and peptides encoded by Mycobacterium tuberculosis-specific RD1 genes. Med Princ Pract 2008;17: 244-249.
70. Mustafa AS, El-Shamy AM, Madi NM, Amoudy HA, Al-Attiyah R. Cell-mediated immune responses to complex and single mycobacterial antigens in tuberculosis patients with diabetes. Med Princ Pract 2008; 17:325-330.
71. Mustafa AS, Al-Attiyah R, Hanif SNM, Shaban FA. Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells. Clin Vaccine Immunol 2008; 15:916-924.
72. Skjøt RL, Oettinger T, Rosenkrands I, et al. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun 2000; 68:214-220.
73. Zhang H, Shi CH, Xue Y, Bai YL, Wang LM, Xu ZK. Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M. tuberculosis in mice. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2006; 22:443-446.
74. Bai Y, Xue Y, Gao H, et al. Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model. Protein Expr Purif 2008; 59:189-196.
75. Maue AC, Waters WR, Palmer MV, et al. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 2007; 25:4735-4746.
76. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356:1099-1104.
77. van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000; 7:155-160.
78. Arend SM, Andersen P, van Meijgaarden KE, et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis 2000;181:1850-1854.
79. Arend SM, Geluk A, van Meijgaarden KE, et al. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun 2000; 68:3314-3321.
80. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183:469-477.
81. Storla DG, Kristiansen I, Oftung F, et al. Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure. BMC Infect Dis 2009; 9:60.
82. Goletti D, Vincenti D, Carrara S, et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005; 12:1311-1316.
83. Weldingh K, Andersen P. Replacing the tuberculin skin test with a specific blood test. Kekkaku 2005;80:581-585.
84. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146:340-354.
85. Ariga H, Harada N. Evolution of IGRA researches. Kekkaku 2008; 83:641-852.
86. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot. TB test in contact investigations for tuberculosis. Chest 2009; 135:1010-1018.
87. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177:1164-1170.
88. Mori T. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 2009; 15:143-155.
89. Barth RE, Mudrikova T, Hoepelman AI. Interferon-gamma release assays (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics? Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting. Int J Infect Dis 2008; 12:e1-6.
90. Dheda K, Smit RZ, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden Vs low-burden settings. Curr Opin Pulm Med 2009; 15:188-200.